SCHEMBL6605322

SCHEMBL6605322

CC([N]C(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
NOS2 P35228 1/20 0.44
LMNA P02545 4/20 0.44
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.43
MAPT P10636 3/20 0.43
ALDH1A1 P00352 3/20 0.43
PTGS1 P23219 2/20 0.43
CXCR1 P25024 2/20 0.43
CXCR2 P25025 2/20 0.43
PTGS2 P35354 2/20 0.43
CYP3A4 P08684 2/20 0.43
RECQL P46063 1/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
MAPK1 P28482 1/20 0.43
PMP22 Q01453 1/20 0.43
SLC22A6 Q4U2R8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6384300 0.81 MAPT (0.45) TDP1L3MBTL1LMNACES2CES1
SCHEMBL3871767 0.79 MAPT (0.44) TDP1L3MBTL1LMNACES2CES1
SCHEMBL4516672 0.78 TSHR (0.43) TDP1L3MBTL1LMNACES2CES1
SCHEMBL7976779 0.78 NOS2 (0.55) NOS2LMNAKDM4EHIF1AMIF
SCHEMBL6607116 0.76 NOS3 (0.49) TDP1L3MBTL1NOS2LMNACES2
SCHEMBL5219001 0.74 NOS2 (0.43) NOS2LMNACES1MAPK1MIF
SCHEMBL7052935 0.74 ALDH1A1 (0.42) TDP1L3MBTL1LMNACES2CES1
SCHEMBL6601283 0.74 PGR (0.44) TDP1L3MBTL1LMNACES2CES1
SCHEMBL6607700 0.73 SLC6A2 (0.44) TDP1L3MBTL1NOS2LMNACES2
SCHEMBL6383659 0.72 NPC1 (0.43) L3MBTL1LMNACES2CES1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1049691-B1 SUBSTITUTED 5-(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL) CYCLOPENTENOPYRIDINE DERIVATIVE BANYU PHARMA CO LTD (JP) 2004-02-18 EP disclosed
US-6413979-B1 ANTAGONISTS TO ENDOTHELINS; VASODILATORS AND BRONCHODILATORS; SYNTHESIS ROUTES; HYPERTENSION, ASTHMA, RAYNAUD'S DISEASE, RENAL AND HEART FAILURE, ANGINA, DIABETES, CEREBRAL INFARC-TION AND VASOSPASM, ARTERIOSCLEROSIS, RESTENOSIS, PROSTATISM BANYU PHARMACEUTICAL CO., LTD. (JP) 2002-07-02 US disclosed
EP-1049691-A1 SUBSTITUTED 5-(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL) CYCLOPENTENOPYRIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2000-11-08 EP disclosed
WO-1999037639-A1 SUBSTITUTED 5-(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL) CYCLOPENTENOPYRIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-07-29 WO disclosed